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Abstract 
It is important to develop new approaches to increase the efficacy of cancer treatments. Nowadays, the uses of 
natural products to treat cancer are very common. In addition, working with plants that are endemic to Palestine 
and determining the biological activities of these plant extracts, is extremely important due to the potential for new 
drug development. Cyclamen persicum is used in traditional medicinal to treat anti-rheumatic, diarrhea, abdominal 
pains, edema, abscesses, eczema, cancer and other ailments. In this study the cytotoxic effect of C. persicum tubers 
and leaves ethanolic extracts were studied against MCF-7, PC-3 and LNCaP cancer cell lines, using mitochondrial 
dehydrogenase enzyme method. Results showed the remarkable cytotoxic activity of C. persicum extracts, against 
breast and prostate adenocarcinoma. For tubers extract the IC50 value was found to be 0.05 mg/ml for the three cell 
lines. Although the leaves extract the IC50 value was found to be 0.25 mg/ml for PC-3 and MCF-7 cell lines, while 
LNCaP cell inhibition were less than 30% at all tested leaves extract concentrations. MCF-7 cells exhibited the 
highest sensitivity to the C. persicum extracts, compared to PC-3 and LNCaP cell lines evaluated. In contrast, 
LNCaP cells generally exhibited the lowest sensitivity to extracts. These results displayed that C. persicum is a 
good source for natural products with antitumor compounds that can be further exploited for the development of 
a potential therapeutic anticancer agent. 
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1. Introduction 
Cancer is a genomic disease that appears as a result of dynamic changes of the DNA of an organism’s cells during 
its life time. The burden of cancer is increasing worldwide with 14.1 million new cancer cases yearly and 8.2 
million cancer deaths occurring in 2012 according to GLOBOCAN series (Ferlay et al., 2014). In Palestine, the 
most common cause of death out of all cancer types was lung cancer among males (22.8 %) and breast cancer 
among females (21.5 %) followed by prostate cancer for males (9.5 %) and by colon cancer for females (11.4 %) 
(Abu-Rmeileh et al., 2016). 
It is important to develop new approaches to increase the antitumor effects against cancer cells in order to 
increase the efficacy of cancer treatments. Today, the uses of natural products to treat cancer are very common, in 
the world. However, some plants have not yet been scientifically proven to exert antitumor activity. Therefore, it 
is very important to study endemic plant extracts with unknown biological activities to possibly develop new drugs 
that will guide the intentional use of natural medicines (Ozcan et al., 2016). 
Regional traditional medicinal plants and herbs will be served as a potential source of novel therapeutic agents. 
A large number of regional medicinal plants are claimed to possess anticancer activity. A systematic review 
conducted in Palestine, by Ali-Shtayeh and Jamous, 2014 identified a total of 368 plant species used in Traditional 
Arabic Palestinian Herbal Medicine (TAPHM) as part of complementary and alternative medicine (CAM). Some 
of these plants claimed to be effective in the treatment of cancer such as Cyclamen persicum, Arum palaestinum, 
Nigella ciliaris, Matricaria aurea, Salvia fruticosa, Zingiber officinale, Anisum vulgare , Allium sativum , 
Trigonella berythea, Curcuma longa, Majorana syriaca , Rosmarinus officinalis, Allium cepa ,Olea europaea, 
Camellia thea , and Teucrium capitatum (Ali- Shtayeh et al., 2000; Khalilia, 2001; Ali-Shtayeh and Jamous, 2008; 
Ali- Shtayeh et al., 2011; Jaradat et al., 2016). Recently, the ability of medicinal plant extracts to control the 
proliferation of cancer cells were reported (Yaacob et al., 2010; Alzeer et al., 2014; Ozcan et al., 2016). 
Cyclamen persicum Mill. is a species of flowering herbaceous perennial plant of the Primulaceae 
family, growing from a tuber, native to rocky hillsides, scrublands, and woodlands in the Mediterranean area. C. 
persicum  used in traditional medicinal to treat antirheumatic, headache,  goiter, antihelmintic, laxative, diarrhea, 
abdominal pains, eye infections, edema, nerve infections, female infertility, open wounds, abscesses, eczema, skin 
burns, toothache, cancer and other ailments (Ali- Shtayeh et al., 2000; Khalilia, 2001; Ali- Shtayeh et al., 2011; 
Fernández-Campos et al., 2019; Al-zuabe et al., 2019). 
To the best of our knowledge C. persicum has not yet been studied for their antitumoral activities against PC-
3 and LNCaP prostate cancer cells and MCF-7 cervical cancer cells. 
The aims of this study, was to demonstrate the antitumor effect of C. persicum on various cancer cell lines, 
to compare the cytotoxicity of tubers and leaves extracts and determining whether their use in folkloric medicine 
to treat cancer disease is justified.  
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2. Materials and methods 
2.1 Plant Collection  
Tubers and leaves of C. persicum were collected between March and July from Nablus mountains (West Bank, 
Palestine) (altitude 600–900 m).  Authentification of the plants was conducted by Prof. Dr. Ali-Shtayeh by 
comparison with plant specimens located at BERC Herbarium and voucher specimens were deposited in the 
Biodiversity and Biotechnology Research Unit at BERC Herbarium, Til, Nablus, Palestine. 
 
2.2 Preparation of crude extracts  
Tubers and leaves of C. persicum (100 g) dried in the shade at room temperature, powdered and infused in 70% 
ethanol (1:5 w/v) at room temperature with periodic shaking for 72h. The filtrates were condensed by evaporating 
the solvents using rotary evaporator, dried under reduced pressure, and stock solutions of 10 mg/ml in dimethyl 
sulphoxide (DMSO) were prepared at room temperature and stored at -20°C.  (Ali-Shtayeh et al., 2013). 
 
2.3 Cell lines 
Prostate cancer PC-3 and LNCaP adenocarcinoma and breast cancer MCF-7 adenocarcinoma cell lines were 
obtained from American Type Culture Collection, USA (ATCC).  MCF-7 and LNCaP cell lines were cultured in 
RPMI-1640 medium (Sigma), while PC-3 cell line was cultured in Minimum Essential Medium (MEM, Sigma). 
Medium were supplemented with 10% fetal calf serum (FCS, Sigma), 2 mM L-Glutamine, 100 IU/ml penicillin 
and 100 μg/ml streptomycin (Sigma). Cell lines were incubated at 37 °C in a humidified incubator containing 5% 
CO2 (Bahk et al., 1998; Kelner et al., 1998; Eilon et al., 2000).  
 
2.4 Cytotoxicity 
Cells were seeded in 96 well- plates at a density of 4x104 cell/ 200µl for LNCaP cells, while 3x104 cells/ 200µl 
for PC-3 and MCF-7cell lines. The cells were allowed to attach in a 5% CO2 incubator at 37° C for 24 h. In order 
to prepare the 4 different doses of extracts (0.05, 0.125, 0.25 and 0.5 mg/ml), crude extract was serially diluted 
into supplemented media using a separate 96-well plate and extract doses applied to the cells. After incubation for 
24 hours viable cells were quantitated by using 3-[4,5-dimethyl thiazol-2-yl]-2,5-diphenyl tetrazolium bromide 
(MTT) (MERCK, Germany) assay. In brief after cells incubation for 24 hours, medium was aspirated carefully 
and discarded. After that 50 µl of MTT solution (1.5mg/ml) was added to each well and incubated for 3 h, then100 
µl of iced acetone-ethanol solution (1:1) were added to dissolve violet crystals. Viability was quantitated by using 
a 96 well- plate reader at 570 nm wavelength, with a reference wave length of 650 nm. The percentage of cell 
survival was determined as (mean of treated wells/ mean of untreated control wells) x100%. DMSO was used as 
a negative control (Srivastava et al., 1998; Ozcan et al., 2016). 
 
2.5 Statistical analysis 
IC50 (50% growth inhibition) values were defined as the concentration of the extract where there is a 50% loss of 
total metabolic activity as compared to untreated controls and are reported as mean ± standard deviation (SD). The 
data were analyzed and the treatment were compared using analysis of variance (ANOVA) obtained by Duncan’s 
multiple-range test and P values less than 0.05 were considered to be significant. All experiments have been 
conducted in three replicates. 
 
3. Results 
In order to evaluate the cytotoxic effect of ethanolic extracts from C. persicum (tubers and leaves), MTT assay 
with three different cancer cell lines (PC3, LNCaP, and MCF-7) were performed. To determine the IC50 value the 
extracts were screened for its cytotoxicity at different concentrations (0.05, 0.125, 0.25 and 0.5 mg/ml).  
When cells treated with ethanolic extract of the tubers and leaves of C. persicum, there was a concentration 
dependent cytotoxic effect. As the concentration increased from 0.05- 0.5 mg, percentage of inhibition increases 
(Table 1). 
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Table 1. Cytotoxicity of C. persicum against PC-3, MCF-7 and LNCaP cells treated with 4 different doses of 
ethanolic extracts after a 24 h. (MTT assay). 
C. persicum 
parts used 
Concentration(mg/ml) % of cell inhibition ± SD. 
PC-3 MCF-7 LNCaP 
Tubers  0.5 94.6 ± 3.5 95.7 ± 2.1 90.3 ± 3.5 
0.25 77.6 ± 4.6 85.2 ± 6.5 79.1 ± 1.5 
0.125 62.3 ± 8.2 73.4 ± 2.1 65.6 ± 3.2 
0.05 45.2 ± 5.2 68.3 ± 7.4 51.1± 3.4 
0 (Control) 0 0 0 
Leaves  0.5 69.4 ± 7.8 63.2 ± 10.6 28.3 ± 7.1 
0.25 60.8 ± 3.9 55.1 ± 8.8 24.9 ± 3.5 
0.125 44.0 ± 7.6 38.3 ± 2.1 23.2 ± 6.4 
0.05 29.3 ± 3.6 28.2 ± 7.4 22.6 ± 5.7 
0 (Control) 0 0 0 
This study showed the remarkable cytotoxic activity of C. persicum extracts, against breast and prostate 
adenocarcinoma. For tubers extract the IC50 value was found to be 0.05 mg/ml for the three cell lines. While the 
leaves extract the IC50 value was found to be 0.25 mg/ml for PC-3 and MCF-7 cell lines, but LNCaP cell inhibition 
were less than 30% at all tested leaves extract concentrations (Table 1. & Figure 1.). 
MCF-7 cells exhibited the highest sensitivity to the C. persicum extracts, with lower IC50 values as compared 
to PC-3 and LNCaP cell lines evaluated. In contrast, LNCaP cells generally exhibited the lowest sensitivity to the 
plant extracts (Table 1).  
                              A 
 
                                     B 
Figure 1. % Cell viability of PC3, LNCaP, and MCF-7 cell lines after 24 hours incubation with ethanolic extracts 
prepared from C. persicum tubers (A) and leaves (B). Cell viability was determined using MTT assay. Results are 
expressed as mean ± S.D (N= 2). 
Figure 1 shows that a significant decrease in cell viability with 0.05, 0.125, 0.25 and 0.5 mg/ml from C. 
persicum tuber extracts after 24 h., and all doses showed viability by 10% at 0.5 mg/ml when compared with the 
control group.  Cell viability decreased with increasing of leaves extracts concentration and all doses showed cell 
viability less than 30% at 0.5 mg/ml extract concentration for PC-3, MCF-7 cell lines. While LNCaP cell viability 
were more than 70% with 0.05, 0.125, 0.25 and 0.5 mg/ml from leave extracts after 24 hours compared with the 
control group (Table 1 & Figure 1). 
C. persicum tubers extract appeared to be the most effective extract compared to the leaves extract applied to 
the PC-3, MCF-7 and LNCaP cells. It can be seen that LNCaP cells were more resistant to the treatment with C. 
persicum tubers extract compared with other cell lines. 
 
4. Discussion 
Most of the currently used anticancer drugs are highly toxic, expensive, and resistance mechanisms pose a 
significant problem (Hait and Hambley, 2009; Alzeer et al., 2014). There is a continuing need to identify new drug 
candidates that are more effective, widely available and less toxic. Plants extracts are an important source of 
potentially useful compounds for the development of new anticancer drugs.  
In our study we investigated ethanolic extraction of C. persicum Palestinian medicinal plant for cytotoxic 
activities against breast and prostate adenocarcinoma cell lines. Results reported that C. persicum showed strong 
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cytotoxic activity against PC-3, MCF-7 and LNCaP cell lines with an inhibition of > 90% at 0.5 mg/ml (Table 1). 
C. persicum is currently used for anticancer treatments in traditional Palestinian medicine (Khalilia, 2001; Ali-
Shtayeh and Jamous, 2008; Ali- Shtayeh et al., 2011). The anti-oxidant properties of this species have been 
previously evaluated, which suggested the possibility of anti-proliferative potential for these plants (Metın et al. 
2013; Mazouz and Djeddi, 2014 and Jaradat et al. 2015). Although the cytotoxicity of C. persicum has been 
previously reported on breast, colon, hepatocellular carcinoma, lung, pancreatic and cervical cancer cell lines 
(Yildiz et al., 2013; El Hosry et al., 2014). Therefore, this plant extracts with significant cytotoxic activity should 
be further assessed using animal models. 
Results of this study shows the inhibitory effect against the three cell lines varied significantly between the 
two C. persicum extracts. At concentration of 0.5 mg/ml, tubers extract was the most toxic (> 90% inhibition). 
While leaves extract showed inhibition effect less than 70%. Cyclamen spp (Primulaceae) are rich in toxic saponins, 
known to have interesting biological activities (Spoerke et al., 1987; Çaliş et al., 1997; Altunkeyik et al., 2012; 
Sajjadi et al., 2016; Stanojević et al., 2018). In a study conducted by El Hosry et al., 2014, showed the remarkable 
cytotoxic activity of saxifragifolin B (saponin derived from cyclamen species), against breast adenocarcinoma and 
lung carcinoma and its chemo protective activity against mitomycin C.  
From our results, MCF-7 cells exhibited the highest sensitivity to the C. persicum extracts, with lower IC50 
values as compared to PC-3 and LNCaP cell lines evaluated. These results are agreement with previous studies on 
various plant extracts (Yaacob et al., 2010; Subarnas et al., 2012). In order to identify the bioactive component(s) 
and to further understand the mechanism of action of C. persicum extracts should be evaluated. 
 
5. Conclusion  
The results of the present study demonstrated that the extracts of C. persicum tubers and leaves possessed strong 
cytotoxic activity and can be easily accessible source of natural anticancer products in cell cultures. C. persicum 
tubers extract appeared to be more effective compared to the leaves extract applied to the PC-3, MCF-7 and LNCaP 
cells. These results justified the use of C. persicum in traditional medicine. 
The researcher decaled that the components responsible for antitumor activity of the extracts of C. persicum 
are unclear. Future studies will be aimed at investigating the effects of different parts of C. persicum upon isolating 
and identifying the substances responsible for the anticancer effects of the solvent extracts. We hope that the results 
of this study will play an important role in designing and developing natural anticancer drugs and will make 
contributions to other studies that might be conducted in this area. 
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